Associations of Community and Individual Social Determinants of Health With Medication Adherence in Patients With Atrial Fibrillation: A Retrospective Cohort Study

被引:5
|
作者
Boyd, Lisa M. [1 ]
Colavecchia, Anthony Carmine [2 ,4 ]
Townsend, Kevin A. [2 ]
Kmitch, Laura [1 ]
Broder, Leah [1 ]
Hegeman-Dingle, Rozelle R. [2 ]
Ateya, Mohammad [2 ]
Lattimer, Alan [1 ]
Bosch, Ryan [1 ]
Alvir, Jose [3 ]
机构
[1] Socially Determined Inc, Washington, DC USA
[2] Pfizer Inc, US Med Affairs, New York, NY USA
[3] US Stat Res & Data Sci Ctr, Pfizer Inc, Global Prod Dev, New York, NY USA
[4] Pfizer Inc, 4037 Pleasant Ridge Dr, Spring, TX 77386 USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 08期
关键词
anticoagulants; atrial fibrillation; medication adherence; social determinants of health; social risk factors; FOOD INSECURITY; RISK-FACTOR; HIV; STROKE;
D O I
10.1161/JAHA.122.026745
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDespite guideline-recommended use of oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF), OAC medication adherence among patients with AF in the United States ranges from 47% to 82%. To characterize potential causes of nonadherence, we analyzed associations between community and individual social risk factors and OAC adherence for stroke prevention in AF. Methods and ResultsA retrospective cohort analysis of patients with AF was conducted using the IQVIA PharMetrics Plus claims data from January 2016 to June 2020, and 3-digit ZIP code-level social risk scores were calculated using American Community Survey and commercial data. Logistic regression models evaluated associations between community social determinants of health, community social risk scores for 5 domains (economic climate, food landscape, housing environment, transportation network, and health literacy), patient characteristics and comorbidities, and 2 adherence outcomes: persistence on OAC for 180 days and proportion of days covered >= 0.80 at 360 days. Of 28 779 patients with AF included in the study, 70.8% of patients were male, 94.6% were commercially insured, and the average patient age was 59.2 years. Multivariable regression found that greater health literacy risk was negatively associated with 180-day persistence (odds ratio [OR]=0.80 [95% CI, 0.76-0.83]) and 360-day proportion of days covered (OR, 0.81 [95% CI, 0.76-0.87]). Patient age and higher AF stroke risk score and AF bleeding risk scores were positively associated with both 180-day persistence and 360-day proportion of days covered. ConclusionsSocial risk domains, such as health literacy, may affect OAC adherence among patients with AF. Future studies should explore associations between social risk factors and nonadherence with greater geographic granularity.
引用
收藏
页数:37
相关论文
共 50 条
  • [1] Impact of Social Determinants of Health on Primary Adherence of Oral Anticoagulants Among Patients with Newly Diagnosed Atrial Fibrillation
    Glowacki, Nicole
    Guzman, Iridian
    Mills, J. Rebecca
    Parks, Ann
    Ateya, Mohammad
    Dai, Feng
    Dorscheid, Holly
    Khatib, Rasha
    CARDIOLOGY AND THERAPY, 2025, 14 (01) : 53 - 69
  • [2] Examining Adherence to Medication in Patients With Atrial Fibrillation The Role of Medication Beliefs, Attitudes, and Depression
    Taylor, Elaina Charlotte
    O'Neill, Mark
    Hughes, Lyndsay D.
    Bennett, Peter
    Moss-Morris, Rona
    JOURNAL OF CARDIOVASCULAR NURSING, 2020, 35 (04) : 337 - 346
  • [3] Impact of treatment adherence on the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation: a retrospective cohort study
    Lee, Won Kyung
    Woo, Seong Ill
    Hyun, Dong Keun
    Jung, Sun-Young
    Kim, Mi-sook
    Lee, Joongyub
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (03) : 216 - 226
  • [4] Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort
    Wilder, Marcee E.
    Zheng, Zhanonian
    Zeger, Scott L.
    Elmi, Angelo
    Katz, Richard J.
    Li, Yixuan
    Mccarthy, Melissa L.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2022, 15 (02): : 116 - 126
  • [5] Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation
    Suzuki, Tsuyoshi
    Shiga, Tsuyoshi
    Omori, Hisako
    Tatsumi, Fujio
    Nishimura, Katsuji
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 238 - 243
  • [6] Association Between Oral Anticoagulant Adherence and Serious Clinical Outcomes in Patients With Atrial Fibrillation: A Long-Term Retrospective Cohort Study
    Safari, Abdollah
    Helisaz, Hamed
    Salmasi, Shahrzad
    Adelakun, Adenike
    De Vera, Mary A.
    Andrade, Jason G.
    Deyell, Marc W.
    Loewen, Peter
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (18):
  • [7] Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: A nationwide cohort study
    Teppo, Konsta
    Jaakkola, Jussi
    Airaksinen, K. E. Juhani
    Airaksinen, Juhani
    Biancari, Fausto
    Halminen, Olli
    Putaala, Jukka
    Mustonen, Pirjo
    Haukka, Jari
    Hartikainen, Juha
    Luojus, Alex
    Niemi, Mikko
    Linna, Miika
    Lehto, Mika
    GENERAL HOSPITAL PSYCHIATRY, 2022, 74 : 88 - 93
  • [8] Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study
    Salmasi, Shahrzad
    Safari, Abdollah
    Kapanen, Anita
    Adelakun, Adenike
    Kwan, Leanne
    MacGillivray, Jenny
    Andrade, Jason G.
    Deyell, Marc W.
    Loewen, Peter
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (11) : 3920 - 3928
  • [9] Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
    Gorst-Rasmussen, A.
    Skjoth, F.
    Larsen, T. B.
    Rasmussen, L. H.
    Lip, G. Y. H.
    Lane, D. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (04) : 495 - 504
  • [10] Cholangitis in patients with atrial fibrillation A retrospective cohort study in Taiwan
    Hu, Wei-Syun
    Lin, Cheng-Li
    MEDICINE, 2022, 101 (06) : E28797